Carmel, IN, United States of America

Michael Parvin Johnson

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2004-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Parvin Johnson: Innovator in Pain Treatment

Introduction

Michael Parvin Johnson is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for pain management. With a total of 3 patents to his name, Johnson's work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents is the Anti-PACAP antibody, which focuses on antibodies to human pituitary adenylate cyclase-activating peptide. This invention includes compositions comprising such antibodies and methods for using them in the treatment of pain, including headache and migraine. This innovative approach aims to provide relief for individuals suffering from these debilitating conditions.

Career Highlights

Michael Parvin Johnson is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to advancing healthcare solutions. His work at Eli Lilly has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Some of his notable coworkers include Chetankumar Natvarlal Patel and Catherine Brautigam Beidler. Their collective expertise and collaboration have played a crucial role in the development of innovative treatments.

Conclusion

In summary, Michael Parvin Johnson is a distinguished inventor whose work in pain treatment through innovative antibodies holds promise for improving patient care. His contributions to the field are significant and reflect a dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…